Review: taking Naproxen sodium and Methylprednisolone together


Summary

Drug interactions are reported among people who take Naproxen sodium and Methylprednisolone together. This review analyzes the effectiveness and drug interactions between Naproxen sodium and Methylprednisolone. It is created by eHealthMe based on reports of 114 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Naproxen sodium and Methylprednisolone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Naproxen Sodium

Naproxen sodium has active ingredients of naproxen sodium. It is often used in pain. (latest outcomes from Naproxen sodium 3,767 users)

Methylprednisolone

Methylprednisolone has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. (latest outcomes from Methylprednisolone 22,523 users)

On Jul, 25, 2016

114 people who take Naproxen Sodium, Methylprednisolone are studied.


Number of reports submitted per year:

Naproxen sodium and Methylprednisolone drug interactions.

Drug effectiveness over time:

Naproxen Sodium:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Methylprednisolone:
n/a

Drug effectiveness by gender:

Naproxen Sodium:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Methylprednisolone:
n/a

Drug effectiveness by age:

Naproxen Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Methylprednisolone:
n/a

Most common drug interactions over time *:

< 1 month:
  • demyelinating polyneuropathy
  • pneumonia
  • depression
  • overdose
  • suicidal ideation
  • culture urine positive
  • dehydration
  • haemoglobin decreased
  • hypokalaemia
  • sinusitis
1 - 6 months:
  • hiatus hernia
  • nausea
  • skin discolouration
  • vomiting
  • abdominal pain
  • abdominal pain upper
  • drug toxicity
  • foot amputation
  • gastric perforation
  • gastric ulcer
2 - 5 years:
  • barrett's oesophagus
  • gastritis
  • nausea
  • vomiting
not specified:
  • pain
  • injury
  • sinusitis
  • arthralgia
  • osteonecrosis of jaw
  • anxiety
  • osteoarthritis
  • pain in extremity
  • anaemia
  • back pain

Most common drug interactions by gender *:

female:
  • pain
  • injury
  • sinusitis
  • anxiety
  • pain in extremity
  • back pain
  • osteonecrosis of jaw
  • decreased interest
  • foramen magnum stenosis
  • metastases to bone
male:
  • arthralgia
  • anaemia
  • injury
  • constipation
  • pain
  • decreased appetite
  • neuropathy peripheral
  • osteoarthritis
  • emotional distress
  • gastrooesophageal reflux disease

Most common drug interactions by age *:

20-29:
  • cholelithiasis
  • injury
  • cholecystitis chronic
  • gallbladder disorder
  • gallbladder non-functioning
  • pain
  • abdominal pain
  • asthmatic crisis
  • back pain
  • blood cholesterol abnormal
30-39:
  • pain in extremity
  • hyperlipidaemia
  • hypertension
  • suicidal ideation
  • deep vein thrombosis
  • pulmonary embolism
  • diabetes mellitus
  • gait disturbance
  • muscle spasms
  • depression
40-49:
  • pneumonia
  • abdominal pain upper
  • anxiety
  • back pain
  • cough
  • deep vein thrombosis
  • dizziness
  • hypoaesthesia
  • insomnia
  • intervertebral disc protrusion
50-59:
  • arthralgia
  • anaemia
  • pain
  • injury
  • osteoarthritis
  • constipation
  • gastrooesophageal reflux disease
  • decreased appetite
  • neuropathy peripheral
  • emotional distress
60+:
  • demyelinating polyneuropathy
  • fall
  • femur fracture
  • foot fracture
  • fracture nonunion
  • gastritis
  • pain in extremity
  • stress fracture
  • barrett's oesophagus
  • bunion

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Naproxen sodium and Methylprednisolone?

Can you answer these questions?

More questions for: Naproxen sodium, Methylprednisolone

You may be interested in these reviews

More reviews for: Naproxen sodium, Methylprednisolone

On eHealthMe, Naproxen sodium (naproxen sodium) is often used to treat pain. Methylprednisolone (methylprednisolone) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.